Table 4. Outcome of patients treated with antifungal drugs.
| Positive | Negative | p (chi-square test) | |
|---|---|---|---|
| AML, n (%) | 79 (76%) | 25 (24%) | 0.04 |
| Positive CT, n (%) | 133 (82%) | 30 (18%) | |
| Negative CT, n (%) | 25 (89%) | 3 (11%) | 0.32 |
| CT not done, n (%) | 22 (73%) | 8 (27%) | |
| Positive GM antigen, n (%) | 33 (80%) | 8 (20%) | |
| Negative GM antigen, n (%) | 133 (82%) | 29 (18%) | 0.89 |
| GM antigen not done, n (%) | 14 (78%) | 4 (22%) | |
| Proven IFI, n (%) | 15 (68%) | 7 (32%) | |
| Probable IFI, n (%) | 48 (79%) | 13 (21%) | |
| Possible IFI, n (%) | 69 (85%) | 12 (15%) | 0.27 |
| Not classifiable, n (%) | 48 (84%) | 9 (16%) | |
| Monotherapy, n (%) | 109 (83%) | 22 (17%) | |
| Sequential or association therapy, n (%) | 66 (81%) | 15 (19%) | 0.75 |
Percentage (%) was calculated on total number of AFTs for each listed category.